AnalystsAaron GalAaron Gal's Stock Forecasts
AnalystsAaron Gal
Analyst Ranking
Bottom 22%
#3615 out of 4569 analysts
Average Return
-5.34%
Win Rate
43%3 out of 7
Risk vs Reward
Poor
Good
Aaron Gal Analyst Color
Get additional color on Aaron Gal's coverage of popular stocks
Aaron Gal's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 3 | Buy | $1,125.00 | +26.05% | Initiates Coverage On | 2 months ago |
Abbvie IncABBV | 1 | Buy | $155.00 | N/A | Maintains | 2 years ago |
Biogen IncBIIB | 2 | Buy | $500.00 | N/A | Upgrades | 3 years ago |
Gilead Sciences IncGILD | 2 | Buy | $80.00 | N/A | Upgrades | 3 years ago |
Viatris IncVTRS | 1 | Hold | $21.00 | N/A | Initiates Coverage On | 3 years ago |
Amgen IncAMGN | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Celgene CorpCELG | 4 | Hold | N/A | N/A | Downgrades | 5 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.